Kind Pharmaceuticals Llc
Clinical trials sponsored by Kind Pharmaceuticals Llc, explained in plain language.
-
New anemia drug for kidney patients enters final testing phase
Disease control Recruiting nowThis study tests a new medicine called AND017 for anemia caused by chronic kidney disease. It is for people with stage 3, 4, or 5 kidney disease who are not yet on dialysis. The study compares AND017 to standard anemia treatments to see if it can safely maintain healthy red blood…
Phase: PHASE3 • Sponsor: Kind Pharmaceuticals LLC • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New hope for MDS patients: drug could reduce need for blood transfusions
Disease control Recruiting nowThis study tests a new drug called AND017 for anemia in people with a type of bone marrow disorder called lower-risk myelodysplastic syndromes (MDS). The goal is to see if the drug can raise hemoglobin levels or reduce the need for blood transfusions. About 63 participants will r…
Phase: PHASE2 • Sponsor: Kind Pharmaceuticals LLC • Aim: Disease control
Last updated May 04, 2026 16:31 UTC